Home/Filings/4/0001179110-18-000394
4//SEC Filing

Bartram Richard 4

Accession 0001179110-18-000394

CIK 0001434868other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 6:01 PM ET

Size

8.8 KB

Accession

0001179110-18-000394

Insider Transaction Report

Form 4
Period: 2018-01-02
Bartram Richard
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-01-02+38,50038,500 total
    Exercise: $66.50Exp: 2028-01-02Common Stock (38,500 underlying)
  • Exercise/Conversion

    Common Stock

    2018-01-02$3.70/sh+17,892$66,20019,092 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-01-02+17,8920 total
    Exercise: $3.70Exp: 2018-04-24Common Stock (17,892 underlying)
Footnotes (2)
  • [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2018.
  • [F2]The options are fully vested as of the date hereof.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001723729

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:01 PM ET
Size
8.8 KB